As there is growing evidence that hypertensive pregnancy disorders are associated with a risk of cardiovascular diseases later, the resolution of hypertension postpartum (PP) is of high clinical significance. However, there is little knowledge about the factors that influence this normalization. The objectives of our study were (a) to investigate whether or not there are differences in the resolution of hypertension between the distinct types of hypertensive pregnancy disorders and (b) to analyse what clinical parameters may determine the resolution pattern PP. In this retrospective study, 52 patients with preeclampsia (PE), seven with HELLP syndrome (haemolysis, elevated liver enzymes, low platelets), 10 with chronic hypertension (CH) and 21 with pregnancy-induced hypertension (PIH) were recruited. The course of the clinical parameters until day 7 PP was documented. Patients with proteinuria (PE/HELLP) showed the highest blood pressure values PP, while patients with PIH and CH showed no blood pressure changes up to day 7 PP. In patients with proteinuric diseases, there was a significantly higher percentage of cases with persisting hypertension at day 3 PP (71% vs 48% PIH/CH group, Po0.05 ), and even at day 7 PP this percentage remained significantly higher (31% vs 19% PIH/CH group). Our study shows that patients with proteinuric pregnancy disorders have a delayed PP of hypertension. A high percentage of these women are discharged from hospital with persisting hypertension and proteinuria. These observations demand a more specific and longterm PP care for these women.
Introduction
The term 'hypertensive pregnancy disorders', which includes diseases such as preeclampsia (PE), pregnancy-induced hypertension (PIH) and HELLP syndrome (haemolysis, elevated liver enzymes, low platelets), implies that the hypertension is linked to pregnancy and that resolution of the diseases occurs after delivery. However, in clinical practice as well as in the academic definitions of those pregnancy complications, hypertension may still be present between 6 and 12 weeks postpartum (PP). A number of studies have shown that women with a hypertensive pregnancy disorder, particularly PE, have an increased risk of chronic hypertension (CH), stroke and other vascular diseases later in life. 1, 2 Thus, the hazard to the health of hypertensive pregnant women is not confined to the period of pregnancy and puerperium. This is supported by the observation that PE shares some risk factors for cardiovascular diseases like endothelial damage, renal alterations and increased systemic inflammatory response. 3 However, routine PP care of women at risk does not adequately address this problem, as the patients are mostly discharged from hospital days after delivery and the later follow-up and surveillance is generally not sufficient because it is too short or does not even exist. Furthermore, knowledge about the factors that determine the PP course and the time of resolution is limited. In addition, it is still unclear which parameters indicate persisting alterations and long-term effects. This lack of knowledge impairs a proper follow-up and counselling of those patients. The aim of our study was to investigate whether or not there are differences in the resolution of hypertension between the distinct types of hypertensive pregnancy disorders and to analyse what clinical parameters may determine the recovery time and the resolution pattern PP.
Patients and methods
In this retrospective study, 52 patients with PE, seven patients with HELLP syndrome, 10 patients with CH and 21 patients with PIH were recruited from the Department of Obstetrics and Gynecology, University of Leipzig. PE and HELLP syndrome were defined according to the guidelines of the International Society for the Study of Hypertension in Pregnancy. Gestational hypertension is defined here as one systolic blood pressure reading of 140 mmHg on any occasion or two consecutive diastolic blood pressure readings of 90 mmHg at least 4 h apart. Significant proteinuria is defined as 300 mg of total protein in a 24-h urine collection or, if this data is not available, 1 þ proteinuria by dipstick on two consecutive occasions at least 4 h apart (Table 1 ). 4 The percentage of patients that needed antihypertensive treatment was 79.2% for the PE group, 71.4% for HELLP, 70.0% for CH and 71.5% for PIH (w 2 ¼ 0.73, P ¼ 0.866). As a first-line oral antihypertensive therapy, a-methyldopa, and as a first-line intravenous therapy, dihydralazine were used. The treatment was discontinued when blood pressure values were normal, or orally continued in patients with persisting hypertension.
The analysis included systolic and diastolic blood pressure as well as proteinuria on the day of delivery, 3 days PP and 7 days PP. The percentage of patients with pathological blood pressure values PPm was calculated.
Statistical comparisons of the blood pressure values were made by the Mann-Whitney test. Differences in the rate of patients with persisting hypertension were assessed by w 2 test using the program (http://home.ubalt.edu/ntsbarsh/Business-stat/ otherapplets/Catego.htm). Statistical significance was set at Po0.05.
Results
Patients without proteinuria (CH and PIH) showed no significant changes in both mean systolic and diastolic blood pressure up to day 7 PP (delivery: 148/91 mmHg, day 3 PP: 143/92 mmHg, day 7 PP: 147/95 mmHg), while patients with proteinuria (PE and HELLP) showed significant decreases in these parameters (PE delivery: 161/100 mmHg, day 3 PP: 156/99 mmHg, day 7 PP: 145/93 mmHg). However, in preeclamptic patients, this normalization occurred not before day 3 PP. Despite this blood pressure decline in proteinuric patients, the percentage of patients with pathological systolic values 4140 mmHg and diastolic values 490 mmHg is significantly higher in the group of proteinuric diseases than in the group of CH and PIH (Table 2 ). In the PE/HELLP group, 29% of the patients had a proteinuria at day 3 PP; at day 7 PP proteinuria was still measurable in 9% of the preeclamptic patients.
Discussion
Our study shows clearly that the resolution pattern of hypertensive pregnancy disorders PP depends on the type of disease. Patients with proteinuria have the highest blood pressure values at delivery compared to patients with CH or PIH. Consequently, these patients exhibit a more drastic blood pressure decrease than the nonproteinuric patients whose blood pressure values do not significantly change during the 7 days period observed. Despite this blood pressure decrease in the proteinuric patients, this group has a significantly higher number of patients with persisting hypertension PP. Obviously, the presence of proteinuria in hypertensive pregnancy diseases is associated with a longer persistence of hypertension PP.
One particular limitation of the study is the fact that the severity of the disease influences the duration of stay in hospital. Thus, the investigation at day 7 PP included mainly patients after caesarean sections or with severe problems, and does not necessarily include relatively healthy women with a rapid recovery who were already discharged from hospital. Nevertheless, our data show that a notable percentage of patients do not have a complete remission of hypertension within the first week after delivery. This is not surprising as the definition of PE includes a recovery time of 12 weeks PP. However, the postclinical follow-up does not usually cover this time range. Our analysis shows that one-third of the proteinuric patients are discharged from hospital with pathological blood pressure requiring further treatment and surveillance. This leads to the demand for a more specific and close postdelivery care for patients with proteinuria in pregnancy.
Moreover, the observation that proteinuric and nonproteinuric patients show a different type of blood pressure pattern after delivery supports the assumption that the pathogenesis of hypertension is different in PE compared to other hypertensive pregnancy diseases. Our observation that a significant proportion of patients with PE are discharged from hospital with persistent symptoms of the disease is of particular interest considering the fact that PE is no longer thought to be a pregnancyrelated condition but one that affects the long-term health of women. There is growing evidence that proteinuric hypertensive diseases in pregnancy are linked to future cardiovascular disease. 1 Routine general postnatal checking does not identify women with an incomplete resolution of the disease who are at greater risk for later cardiovascular complications. A previously reported audit showed that even at the 6-week postnatal check women are checked neither for hypertension (6%) nor for proteinuria (68%). 5 Our data shows that proteinuria in pregnancy indicates an increased likelihood for longer lasting hypertension after delivery. The PP treatment of these particular women has to address the potential disposition for cardiovascular diseases. As a consequence, women with a persistence of symptoms after the usual stay in hospital, have to be clearly identified since they have markers for chronic or future disease. Future studies are needed to show in more detail, which patients are at risk of cardiovascular diseases later. For these women, a special counselling for the avoidance of additional risk factor like obesity and specialized care following pregnancy are required. Moreover, a prospective study with an extended monitoring of patients after delivery might clarify which patients with persisting hypertension or microalbuminuria could possible benefit from an early therapeutic intervention in order to avoid or reduce long-term cardiovascular and renal damage. What is known about the topic K In women with hypertensive pregnancy disorders the remission of hypertension occurs in a period of weeks postpartum and not immediately after delivery. 4 K Hypertensive pregnancy disorders are associated with a risk for later cardiovascular diseases such as myocardial infarction and stroke.
1,2
What this study adds K The resolution pattern of hypertensive pregnancy disorders postpartum depends on the type of the disease. K Patients with proteinuric pregnancy disorders have a delayed postpartum remission of hypertension compared to those without proteinuria. K A high percentage of these patients are discharged from hospital with persisting symptoms (hypertension/ proteinuria) and need longer and specialized surveillance.
